Grape Exosomes Market Set for Strong Growth as Demand Rises in Health and Beauty Sectors

The global market for grape exosomes is experiencing rapid growth, according to a new report released by Global Info Research. The study, published on September 9, provides a detailed analysis of the grape exosomes industry from 2025 to 2031. Grape exosomes are extracellular vesicles derived from grapes, with applications in pharmaceuticals, health products, skin care, and scientific research. These plant-based nanoparticles are gaining attention for their unique biological properties and potential uses across several industries.

The report estimates that the global grape exosomes market was valued at $33.9 million in 2024. Projections indicate that the market will reach $95.6 million by 2031, representing a compound annual growth rate (CAGR) of 16 percent during the forecast period. This significant growth is attributed to increasing demand for natural and plant-derived ingredients in health and beauty products, as well as ongoing research into the therapeutic potential of exosomes.

Key players identified in the market include Creative Biostructure, SBS Genetech, CD Bioparticles, Covalo, and Creative Biolabs. These companies are involved in developing and commercializing grape exosome products for various applications. The report highlights that competition is intensifying as more manufacturers enter the market and invest in research and development.

The study covers major regions including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America remains a leading market due to strong demand from the pharmaceutical and cosmetic sectors. Europe and Asia-Pacific are also showing robust growth, driven by increased consumer awareness of natural health products and expanding research activities.

Grape exosomes are categorized by type based on their composition: RNA-enriched, polyphenol/antioxidant-enriched, and lipid-dominated. Each type offers different benefits and is used in specific applications. For example, antioxidant-enriched exosomes are popular in skin care formulations for their protective properties, while RNA-enriched types are being studied for their role in drug delivery systems.

The report also examines supply chain dynamics, noting that the industry relies on both established suppliers and emerging companies specializing in biotechnology. It discusses how international trade policies and tariffs may impact market competitiveness and supply chain resilience over the coming years.

Data for the report was collected from a range of sources including customs statistics, industrial associations, company filings, interviews with industry experts, and proprietary databases maintained by Global Info Research. The analysis includes both quantitative data—such as sales figures and market share—and qualitative insights into trends shaping the industry.

As interest in plant-based therapeutics continues to grow worldwide, grape exosomes are expected to play an increasingly important role in product innovation across pharmaceuticals, cosmetics, and scientific research fields. The report suggests that ongoing technological advancements and expanding applications will continue to drive market expansion through 2031.